Form D · Biotechnology
OMNI BIO PHARMACEUTICAL, INC.
Fort Collins, CO · CIK 0001389870
Offering snapshot reported Mar 16, 2015 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 11, 2013 | Initial | $1,540,000 | No comparison | 12 | SEC filing |
| Jun 1, 2012 | Initial | $687,500 | No comparison | 5 | SEC filing |
| Jun 14, 2011 | Initial | $3,079,875 | No comparison | 31 | SEC filing |
| Feb 10, 2010 | Amendment | $1,985,650 | $1,595,650vs Jan 11, 2010 | 31 | SEC filing |
| Jan 11, 2010 | Initial | $390,000 | No comparison | 9 | SEC filing |
| Apr 7, 2009 | Initial | $1,870,000 | No comparison | Not reported | SEC filing |
| Apr 7, 2009 | Initial | $20,292,075 | No comparison | Not reported | SEC filing |
| Apr 7, 2009 | Amendment | $20,292,075 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-235944
Offering is for up to $1 million
Assumes 10% fee on max. $1 million to be raised & warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Spencer Edwards Investments | 22067 |
Source: Form D, filed Mar 16, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vicki Barone | Director |
| Steven Bathgate | Director |
| James Crapo | Director, Executive |
| Charles Dinarello | Executive |
| Michael Iseman | Director |
| Michael Kamarck | Director |
| Brian Klemsz | Director |
| Albert Kramer | Director |
| Ed Larkin | Executive |
| Edward Larkin | Executive |
| Joseph Lavigne | Promoter |
| Robert Ogden | Executive |
| John F. Riccardi | Executive |
| Bruce E. Schneider | Director, Executive |
| Rick Seefried | Promoter |
| Jeffrey Sperber | Director |
| Michael Wort | Director |
| Sandy Wrobel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
181 W Boardwalk Drive Suite 202
Fort Collins, CO, 80525
Fort Collins, CO, 80525